Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Testing brain stimulation effects on movement in people with an implanted device

Tests motor thalamus stimulation in adults with movement disorders, with and without stimulation.

Plain-language title generated from the registry record
Registry title: Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function

Key facts

Where
Pittsburgh, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT07056348, who can take part

Where in United States

  • University of PittsburghPittsburgh, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Jorge Gonzalez-Martinez
Trial code
NCT07056348
Record updated
18 September 2026
Original description
This study aims to recruit patients already implanted with Deep Brain Stimulation (DBS) for movement disorders to complete tasks assessing parameters of motor output, speech, and swallowing functions, both with and without stimulation. DBS parameters would be adjusted prior to motor testing. Patients would then participate in multiple sessions performing contralateral upper extremity movement tasks measuring movement speed, grip strength, and strength modulation, facial movement, swallowing, and speech tasks.Read full original descriptionShow less

Chronic Stimulation of the Motor Ventral Thalamus (VOP/VIM) for Motor Control in Humans

This study aims to recruit patients already implanted with Deep Brain Stimulation (DBS) for movement disorders to complete tasks assessing parameters of motor output, speech, and swallowing functions, both with and without stimulation. DBS parameters would be adjusted prior to motor testing. Patients would then participate in multiple sessions performing contralateral upper extremity movement tasks measuring movement speed, grip strength, and strength modulation, facial movement, swallowing, and speech tasks.

Inclusion: Movement disorder patients ≥18 years of age and < 80 years of age, who will be implanted with DBS for treatment of motor symptoms; Subject has provided written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization, where applicable, prior to any study-related procedures.

Exclusion: History of seizure disorders; Any serious disease or disorder (e.g. cancer, severe cardiac or respiratory disease, neurological conditions other than current movement disorder) or cognitive impairments that could impair ability to participate in this study; Vasovagal response history and loss of consciousness history; Severe behavioral or cognitive problems that preclude participation in the study, in the opinion of the investigator would impact participation in the study; Females who are pregnant or breastfeeding.

ClinicalTrials.gov NCT07056348